EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 12 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,473,644 | +6.2% | 146,340 | +4.5% | 0.00% | 0.0% |
| Q3 2022 | $1,388,000 | +3.4% | 140,047 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $1,342,000 | -0.3% | 137,503 | +0.3% | 0.00% | – |
| Q1 2022 | $1,346,000 | -1.0% | 137,103 | -0.0% | 0.00% | – |
| Q4 2021 | $1,359,000 | -0.1% | 137,107 | +0.0% | 0.00% | – |
| Q3 2021 | $1,361,000 | -0.7% | 137,106 | +0.0% | 0.00% | -100.0% |
| Q2 2021 | $1,370,000 | +8.9% | 137,104 | +9.7% | 0.00% | 0.0% |
| Q1 2021 | $1,258,000 | – | 125,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exos Asset Management LLC | 50,000 | $502,000 | 0.39% |
| Arena Capital Advisors, LLC- CA | 300,000 | $3,020,000 | 0.30% |
| MMCAP International Inc. SPC | 250,000 | $2,516,000 | 0.25% |
| PERISCOPE CAPITAL INC. | 350,000 | $3,523,000 | 0.14% |
| Kepos Capital LP | 175,000 | $1,761,000 | 0.11% |
| Ghisallo Capital Management LLC | 150,000 | $1,508,000 | 0.10% |
| Shaolin Capital Management LLC | 200,000 | $2,013,000 | 0.08% |
| Atalaya Capital Management LP | 40,000 | $402,000 | 0.08% |
| Radcliffe Capital Management, L.P. | 200,000 | $2,013,000 | 0.08% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 57,789 | $581,000 | 0.07% |